Skip to Content

COVID-19 Info: Please help us slow the spread of coronavirus - Wear a Mask, Wash Your Hands & Wait 6 Feet Apart!
Visitor Policies and Precautions | COVID-19 Testing| Vaccine information | Commitment to Safety | Current Numbers

Clinical Trials Details

NRG BR003

Patient Information

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer.

Learn more about clinical trial - NRG BR003

Clinical Trial Categories

  • Breast Cancer - Adjuvant

Location

  • Cone Health Cancer Center at Alamance Regional
    1236 Huffman Mill Rd.
    Burlington, NC 27215
    Main: 336-538-7725
  • Cone Health Cancer Center at Wesley Long
    2400 W. Friendly Avenue
    Greensboro, NC 27403
    Main: 336-832-1100